Medimmune Sues Sun Pharma Over Plans For Ethyol Generic
The lawsuit, filed in U.S. District Court for the District of Maryland, accused the Indian drug maker of patent infringement and seeks a preliminary and permanent injunction barring the company from making Ethyol.
Ethyol is used as an adjunct to cancer therapy, which protects against the side effects of chemotherapy and radiation treatment. Ethyol injection is reported to reduce toxicities associated with cancer...
To view the full article, register now.